UNITED KINGDOM HAEMOPHILIA CENTRE DOCTORS ORGANISATION
Annual General Meeting and educational meeting. Regular meetings of the executive committee to discuss inter alia: reports from working parties; management of haemophilia database; procurement of clotting factor - advice to DoH. Working parties in different subspecialties perform audits, research and produce guidelines for optimal patient management. Recommendation of standards of care.
Financial health, per its FY2025 accounts
The accounts state that unrestricted funds increased to £335,500, resulting from a net incoming resource surplus of £14,650 against voluntary income of £50,080. The Trustees confirmed that the charity has sufficient resources to meet its liabilities as they fall due and identified no material uncertainties regarding its ability to continue as a going concern.
What the accounts disclose
“UKHCDO owns all the issued share capital of UKHCDO Limited. UKHCDO Limited is therefore wholly controlled by the Trustees of UKHCDO.” — page 4
Trustees
- Professor Pratima Chowdary Mamillapallichair
- Dr Gary Michael Benson
- Dr Kate Talks
- Dr Mary Charlotte Mathias
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £50k | £35k |
| 31/03/2024 | £50k | £617 |
| 31/03/2023 | £70k | £425 |
| 31/03/2022 | £120 | £395 |
| 31/03/2021 | £160 | £9k |
Common questions
Is UNITED KINGDOM HAEMOPHILIA CENTRE DOCTORS ORGANISATION financially healthy?
Per its FY2025 accounts: The accounts state that unrestricted funds increased to £335,500, resulting from a net incoming resource surplus of £14,650 against voluntary income of £50,080. The Trustees confirmed that the charity has sufficient resources to meet its liabilities as they fall due and identified no material uncertainties regarding its ability to continue as a going concern. Its FY2025 accounts were independently examined.